CITIC Securities: The Federal Reserve Will Cut Rates No More Than Twice This Year
Odaily Planet Daily News: According to a research report by CITIC Securities, U.S. inflation in June largely maintained a "calm and stable" state, with core CPI growth coming in below expectations for the fifth consecutive month, mainly due to cooling rent inflation and used car prices. This softer core inflation reading does not support the hypothesis that "tariffs have only a minor impact on inflation." In fact, our tracking indicators, such as the "CPI with high import content," show that tariffs have already begun to affect the prices of U.S. import-sensitive end consumer goods. We still believe there are concerns about a rebound in U.S. inflation, the likelihood of a Fed rate cut in July is low, and there may be at most two rate cuts this year. The room for continued weakness in the U.S. dollar may be limited, and the current attractiveness of U.S. Treasuries as an allocation may still not be strong. (Jin10)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Simwon America (SWA.US) applies for Nasdaq IPO, plans to raise up to $50 million
Simwon America, a manufacturer of structural components for electric vehicles, filed for an IPO with the U.S. Securities and Exchange Commission (SEC) last Friday, aiming to raise up to $50 million. The company is a spinoff of Korea’s MS Autotech.
Sui Foundation Invests $30M in DATA Network as It Moves to Sui post-167040 post-167040 post-167040

Equities: Stable oil and yields support stock gains - Danske Bank
Dental caries treatment provider vVardis (VVVV.US) submits US IPO application, expected to raise 200 million USD
vVardis Holding filed for an initial public offering (IPO) with the U.S. Securities and Exchange Commission (SEC) last Friday. The company focuses on self-developed non-invasive restorative therapies for the early treatment of dental caries. The IPO is expected to raise 200 millions USD.
